Cargando…

N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae

BACKGROUND: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. In addition to its highly debilitating motor symptoms, non-motor symptoms may precede their motor counterparts by many years, which may characterize a prodromal phase of PD. A potential pharmacological strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Benvenutti, Radharani, Marcon, Matheus, Reis, Carlos G., Nery, Laura R., Miguel, Camila, Herrmann, Ana P., Vianna, Monica R.M., Piato, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985760/
https://www.ncbi.nlm.nih.gov/pubmed/29868300
http://dx.doi.org/10.7717/peerj.4957
_version_ 1783328814251638784
author Benvenutti, Radharani
Marcon, Matheus
Reis, Carlos G.
Nery, Laura R.
Miguel, Camila
Herrmann, Ana P.
Vianna, Monica R.M.
Piato, Angelo
author_facet Benvenutti, Radharani
Marcon, Matheus
Reis, Carlos G.
Nery, Laura R.
Miguel, Camila
Herrmann, Ana P.
Vianna, Monica R.M.
Piato, Angelo
author_sort Benvenutti, Radharani
collection PubMed
description BACKGROUND: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. In addition to its highly debilitating motor symptoms, non-motor symptoms may precede their motor counterparts by many years, which may characterize a prodromal phase of PD. A potential pharmacological strategy is to introduce neuroprotective agents at an earlier stage in order to prevent further neuronal death. N-acetylcysteine (NAC) has been used against paracetamol overdose hepatotoxicity by restoring hepatic concentrations of glutathione (GSH), and as a mucolytic in chronic obstructive pulmonary disease by reducing disulfide bonds in mucoproteins. It has been shown to be safe for humans at high doses. More recently, several studies have evidenced that NAC has a multifaceted mechanism of action, presenting indirect antioxidant effect by acting as a GSH precursor, besides its anti-inflammatory and neurotrophic effects. Moreover, NAC modulates glutamate release through activation of the cystine-glutamate antiporter in extra-synaptic astrocytes. Its therapeutic benefits have been demonstrated in clinical trials for several neuropsychiatric conditions but has not been tested in PD models yet. METHODS: In this study, we evaluated the potential of NAC to prevent the damage induced by 6-hydroxydopamine (6-OHDA) on motor, optomotor and morphological parameters in a PD model in larval zebrafish. RESULTS: NAC was able to prevent the motor deficits (total distance, mean speed, maximum acceleration, absolute turn angle and immobility time), optomotor response impairment and morphological alterations (total length and head length) caused by exposure to 6-OHDA, which reinforce and broaden the relevance of its neuroprotective effects. DISCUSSION: NAC acts in different targets relevant to PD pathophysiology. Further studies and clinical trials are needed to assess this agent as a candidate for prevention and adjunctive treatment of PD.
format Online
Article
Text
id pubmed-5985760
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-59857602018-06-04 N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae Benvenutti, Radharani Marcon, Matheus Reis, Carlos G. Nery, Laura R. Miguel, Camila Herrmann, Ana P. Vianna, Monica R.M. Piato, Angelo PeerJ Neuroscience BACKGROUND: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. In addition to its highly debilitating motor symptoms, non-motor symptoms may precede their motor counterparts by many years, which may characterize a prodromal phase of PD. A potential pharmacological strategy is to introduce neuroprotective agents at an earlier stage in order to prevent further neuronal death. N-acetylcysteine (NAC) has been used against paracetamol overdose hepatotoxicity by restoring hepatic concentrations of glutathione (GSH), and as a mucolytic in chronic obstructive pulmonary disease by reducing disulfide bonds in mucoproteins. It has been shown to be safe for humans at high doses. More recently, several studies have evidenced that NAC has a multifaceted mechanism of action, presenting indirect antioxidant effect by acting as a GSH precursor, besides its anti-inflammatory and neurotrophic effects. Moreover, NAC modulates glutamate release through activation of the cystine-glutamate antiporter in extra-synaptic astrocytes. Its therapeutic benefits have been demonstrated in clinical trials for several neuropsychiatric conditions but has not been tested in PD models yet. METHODS: In this study, we evaluated the potential of NAC to prevent the damage induced by 6-hydroxydopamine (6-OHDA) on motor, optomotor and morphological parameters in a PD model in larval zebrafish. RESULTS: NAC was able to prevent the motor deficits (total distance, mean speed, maximum acceleration, absolute turn angle and immobility time), optomotor response impairment and morphological alterations (total length and head length) caused by exposure to 6-OHDA, which reinforce and broaden the relevance of its neuroprotective effects. DISCUSSION: NAC acts in different targets relevant to PD pathophysiology. Further studies and clinical trials are needed to assess this agent as a candidate for prevention and adjunctive treatment of PD. PeerJ Inc. 2018-06-01 /pmc/articles/PMC5985760/ /pubmed/29868300 http://dx.doi.org/10.7717/peerj.4957 Text en © 2018 Benvenutti et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Neuroscience
Benvenutti, Radharani
Marcon, Matheus
Reis, Carlos G.
Nery, Laura R.
Miguel, Camila
Herrmann, Ana P.
Vianna, Monica R.M.
Piato, Angelo
N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae
title N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae
title_full N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae
title_fullStr N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae
title_full_unstemmed N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae
title_short N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae
title_sort n-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-ohda in zebrafish larvae
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985760/
https://www.ncbi.nlm.nih.gov/pubmed/29868300
http://dx.doi.org/10.7717/peerj.4957
work_keys_str_mv AT benvenuttiradharani nacetylcysteineprotectsagainstmotoroptomotorandmorphologicaldeficitsinducedby6ohdainzebrafishlarvae
AT marconmatheus nacetylcysteineprotectsagainstmotoroptomotorandmorphologicaldeficitsinducedby6ohdainzebrafishlarvae
AT reiscarlosg nacetylcysteineprotectsagainstmotoroptomotorandmorphologicaldeficitsinducedby6ohdainzebrafishlarvae
AT nerylaurar nacetylcysteineprotectsagainstmotoroptomotorandmorphologicaldeficitsinducedby6ohdainzebrafishlarvae
AT miguelcamila nacetylcysteineprotectsagainstmotoroptomotorandmorphologicaldeficitsinducedby6ohdainzebrafishlarvae
AT herrmannanap nacetylcysteineprotectsagainstmotoroptomotorandmorphologicaldeficitsinducedby6ohdainzebrafishlarvae
AT viannamonicarm nacetylcysteineprotectsagainstmotoroptomotorandmorphologicaldeficitsinducedby6ohdainzebrafishlarvae
AT piatoangelo nacetylcysteineprotectsagainstmotoroptomotorandmorphologicaldeficitsinducedby6ohdainzebrafishlarvae